@logan123 "l believe with the potential of PTX100 these investors will elevate their holdings substantially which traditionally they are likely to top up from the open market. And l don't think any of the top 20 will have a say in this including myself."
I am curious why the top 20 feel they would have a say in a pharma entering the stock on the open market. Surely if a pharma elevated a position it would be a win-win for everyone? While I am not a top 20 holder in this particular company, I do understand the need to have cornerstone investors, and moreso if they are in the related industry. I am trying to understand your comment only on the premise it's based on an open market transaction and not through internal means. Cheers
Add to My Watchlist
What is My Watchlist?
